Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Piccart

Showing results (1-10 of 186) with videos related to

Pageof 19
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 13, 2001
Closing remarks and treatment guidelinesM Piccart
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2013
Personalised cancer management: closer, but not here yetM Piccart
Anti-Cancer Drugs|July 1, 1995
Docetaxel: a new defence in the management of breast cancerM Piccart
European Journal of Cancer (Oxford, England : 1990)|May 9, 2001
Closing remarks and treatment guidelinesM Piccart
Anti-Cancer Drugs|August 1, 1996
Treatment of advanced breast cancer: current statusM Piccart
Cancer Treatment Reviews|July 1, 1997
New cytotoxic agentsM Piccart
Seminars in Oncology|April 15, 1999
What can be expected from the next generation of adjuvant breast cancer treatment?M Piccart-Gebhart
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
The third-generation non-steroidal aromatase inhibitors: a review of their clinical benefits in the second-line hormonal treatment of advanced breast cancerA Hamilton, M Piccart
European Journal of Cancer (Oxford, England : 1990)|February 13, 2001
Introduction. Herceptin: HER2 status--changing clinical practiceM Piccart, M Kaufmann
Clinical Breast Cancer|March 20, 2002
HER2/neu as a predictive factor in breast cancerC Lohrisch, M Piccart
Pageof 19

Showing results (1-10 of 186) with videos related to

Sort By:
Pageof 19
European Journal of Cancer (Oxford, England : 1990)|February 13, 2001
Closing remarks and treatment guidelinesM Piccart
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2013
Personalised cancer management: closer, but not here yetM Piccart
Anti-Cancer Drugs|July 1, 1995
Docetaxel: a new defence in the management of breast cancerM Piccart
European Journal of Cancer (Oxford, England : 1990)|May 9, 2001
Closing remarks and treatment guidelinesM Piccart
Anti-Cancer Drugs|August 1, 1996
Treatment of advanced breast cancer: current statusM Piccart
Cancer Treatment Reviews|July 1, 1997
New cytotoxic agentsM Piccart
Seminars in Oncology|April 15, 1999
What can be expected from the next generation of adjuvant breast cancer treatment?M Piccart-Gebhart
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
The third-generation non-steroidal aromatase inhibitors: a review of their clinical benefits in the second-line hormonal treatment of advanced breast cancerA Hamilton, M Piccart
European Journal of Cancer (Oxford, England : 1990)|February 13, 2001
Introduction. Herceptin: HER2 status--changing clinical practiceM Piccart, M Kaufmann
Clinical Breast Cancer|March 20, 2002
HER2/neu as a predictive factor in breast cancerC Lohrisch, M Piccart
Pageof 19